Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.18 +0.11 (+5.69%)
As of: Oct 21, 2026 · 10:58 AM EDT

Kalaris Therapeutics (KLRS) Common Stock Issued (2021 - 2026)

Updated

Analysis

Kalaris Therapeutics (KLRS) Common Stock Issued (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 359.00 Mn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 6.00 Mn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 9.00 Mn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Kalaris Therapeutics 51.93 Mn -41.57 Mn - 10,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10,000.00
Mar 31, 2026 74,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 -20,000.00
Dec 31, 2023 11,000.00
Dec 31, 2022 292,000.00
Sep 30, 2022 126.43 Mn
Dec 31, 2021 65,000.00
API Access

Kalaris Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=KLRS&period=max&api_key=YOUR_API_KEY